Safety study of FTL008.16 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational drug called FTL008.16 for people with advanced solid tumors that may carry a protein called 5T4. The main goal is to see if the drug is safe and tolerable.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 75 years old.
- You have an advanced solid tumor that has continued to grow after standard treatments, or you cannot tolerate those treatments.
- You have at least one tumor that can be seen on a CT or MRI scan.
- Your daily activities are mostly normal (ECOG score 0 or 1).
- You must provide a tumor tissue sample (either a fresh biopsy or one from a previous surgery).
- If you could become pregnant or father a child, you must use effective birth control during the study and for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called FXB0871 in people with advanced solid tumors that have stopped responding to standard treatments or for whom no standard treatment exists. The goal is to see if the drug is safe and effective, and patients who enroll will receive close monitoring throughout the study.
This trial tests an experimental drug called Hemay5087 for people with advanced solid tumors. It aims to find out if the drug is safe and how well it works, offering a possible option when standard treatments have failed.
This trial tests a new drug called FTL001 for people with advanced solid tumors that have not improved with standard therapy. The goal is to see if it is safe and how well it works.
This trial tests a new drug that may help people with advanced solid tumors, including liver, stomach, and brain cancers. It is for patients whose cancer has not responded to standard treatments or who cannot have them. The study aims to find the right dose and check safety and effectiveness.
This trial tests a new drug called BT02 for people with advanced solid tumors who have not had any cancer treatment before. It aims to see if BT02 is safe and how well it works.
This early-phase trial tests a new drug (CD-001) for people with advanced solid tumors. It will check if the drug is safe, how the body handles it, and if it helps shrink tumors.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.